Acute consequences of hypoglycaemia in diabetic patients;Conséquences à court terme des hypoglycémies cheze les diabétiques.

Diabetes and Metabolism

Volumn 36, Issue SUPPL. 3, 2010, Pages

  Halimi, S ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Brain damage; Cardiovascular complication; Dead in bed syndrome; Diabetes; Driving; Hypoglycaemia; Review

Indexed keywords

GLUCOSE; INSULIN; SULFONYLUREA DERIVATIVE;

ARTICLE; BRAIN DAMAGE; CARDIOVASCULAR DISEASE; COGNITIVE DEFECT; DIABETIC PATIENT; DISEASE SEVERITY; GLYCEMIC CONTROL; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HUMAN; HYPOGLYCEMIA; IATROGENIC DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; MORTALITY; NEUROLOGICAL COMPLICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT EDUCATION; QT PROLONGATION; RECURRENCE RISK; STROKE;

CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; HUMANS; HYPOGLYCEMIA; RISK FACTORS;

EID: 78650796319     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(10)70471-7     Document Type: Article

References (55)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977-986. The Diabetes Control and Complications Trial Research Group.
2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352:837-853. UK Prospective Diabetes Study (UKPDS) Group.
3. Gerstein H.C., Miller M.E., Byington R.P., Goff D.C., Bigger J.T., Buse J.B., et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008, 358:2545-2559. Action to Control Cardiovascular Risk in Diabetes Study Group.
4. Duckworth W., Abraira C., Moritz T., Reda D., Emanuele N., Reaven P.D., et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009, 360:129-139. VADT Investigators, Erratum in: N Engl J Med 2009;361:1028. N Engl J Med 2009;361:1024-5.
5. Holman R.R., Paul S.K., Bethel M.A., Matthews D.R., Neil H.A. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008, 359:1577-1589.
6. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 2003, 290:2159-2167. Writing Team for the Diabetes Control Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.
7. Cryer P.E. Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes. Diabetologia 2002, 45:937-948.
8. Zammitt N.N., Frier B.M. Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care 2005, 28:2948-2961.
9. ter Braak E.W., Appelman A.M., van de Laak M., Stolk R.P., van Haeften T.W., Erkelens D.W. Clinical characteristics of type 1 diabetic patient with and without severe hypoglycemia. Diabetes Care 2000, 23:1467-1471.
10. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007, 50:1140-1147. UK Hypoglycaemia Study Group.
11. Gerstein H., Yusuf S., Riddle M.C., Ryden L., Bosch J. Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention). Am Heart J 2008, 155:26-32. Origin Trial Investigators.
12. Jørgensen H.V., Pedersen-Bjergaard U., Rasmussen A.K., Borch-Johnsen K. The Impact of severe hypoglycemia and impaired awareness of hypoglycemia on relatives of patients with type 1 diabetes. Diabetes Care 2003, 26:1106-1109.
13. Bolli G., de Feo P., Compagnucci P., Cartechini M.G., Angeletti G., Santeusanio, et al. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus: interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes 1983, 32:134-141.
14. Henderson J.N., Allen K.V., Deary I.J., Frier B.M. Hypoglycaemia in insulin-treated Type 2 diabetes: frequency, symptoms and impaired awareness. Diabet Med 2003, 20:1016-1021.
15. Holman R.R., Farmer A.J., Davies M.J., Levy J.C., Darbyshire J.L., Keenan J.F., et al. Three-year efficacy of complex insulin regimens in type 2 diabetes. N Engl J Med 2009, 361:1736-1747. 4-T Study Group.
16. Shorr R.I., Ray W.A., Daugherty J.R., Griffin M.R. Incidence and risk factors for serious hypoglycemia in older persons using iwnsulin or sulfonylureas. Arch Intern Med 1997, 25:1681-1686.
17. Bruce D.G., Davis W.A., Casey G.P., Clarnette R.M., Brown S.G., Jacobs I.G., et al. Severe hypoglycaemia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes Study. Diabetologia 2009, 52:1808-1815.
18. Patel A., MacMahon S., Chalmers J., Neal B., Billot L., Woodward M., et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008, 358:2560-2572. ADVANCE Collaborative Group.
19. Dahlquist G., Källén B. Mortality in childhood-onset type 1 diabetes: a population-based study. Diabetes Care 2005, 28:2384-2387.
20. Lonnen K.F., Powell R.J., Taylor D., Shore A.C., MacLeod K.M. Road traffic accidents and diabetes: insulin use does not determine risk. Diabet Med 2008, 25:578-584.
21. Tattersall R.B., Gill G.V. Unexplained deaths of type 1 diabetic patients. Diabet Med 1991, 8:49-58.
22. Strouse S.S.S., Katz L.N. Rubinfield SH Treatment of older diabetic patients with cardiovascular disease. JAMA 1932, 98:1703-1706.
23. Frye R.L., August P., Brooks M.M., Hardison R.M., Kelsey S.F., MacGregor J.M., et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009, 360:2503-2515. BARI 2D Study Group.
24. Egeli E.S., Berkman R. Action of hypoglycemia on coronary insufficiency and mechanism of ECG alterations. Am Heart J 1960, 59:527-540.
25. Desouza C., Salazar H., Cheong B., Murgo J., Fonseca V. Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring. Diabetes Care 2003, 26:1485-1489.
26. Desouza C.V., Bolli G.B., Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care 2010, 33:1389-1394.
27. Gill G.V., Woodward A., Casson I.F., Weston P.J. Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes--the 'dead in bed'syndrome revisited. Diabetologia 2009, 52:42-45.
28. Robinson R.T., Harris N.D., Ireland R.H., Macdonald I.A., Heller S.R. Changes in cardiac repolarization during clinical episodes of nocturnal hypoglycaemia in adults with Type 1 diabetes. Diabetologia 2004, 47:312-315.
29. Lindstrom T., Jorfeldt L., Tegler L., Arnqvist H.J. Hypoglycaemia and cardiac arrhythmias in patients with type 2 diabetes mellitus. Diabet Med 1992, 9:536-541.
30. Roberts J.D., Gollob M.H. The genetic and clinical features of cardiac channelopathies. Future Cardiol. 2010, 6:491-506.
31. Weston P.J., Gill G.V. Is undetected autonomic dysfunction responsible for sudden death in type 1 diabetes mellitus? The dead in bed'syndrome revisited. Diabet Med 1999, 16:626-631.
32. Karavanaki K., Kazianias G., Kakleas K., Konstantopoulos I., Karayianni C. QT interval prolongation in association with impaired circadian variation of blood pressure and heart rate in adolescents with type 1 diabetes. Diabet Med 2007, 24:1247-1253.
33. Turchin A., Matheny M.E., Shubina M., Scanlon J.V., Greenwood B., Pendergrass M.L. Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward. Diabetes Care 2009, 32:1153-1157.
34. Razavi Nematollahi L., Kitabchi A.E., Kitabchi A.E., Stentz F.B., Wan J.Y., Larijani B.A., et al. Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects. Metabolism 2009, 58:443-448.
35. Feldman-Billard S., Massin P., Meas T., Guillausseau P.J., Héron E. Hypoglycemia-induced blood pressure elevation in patients with diabetes. Arch Intern Med 2010, 170:829-831.
36. Sakel M. The methodical use of hypoglycemia in the treatment of psychoses.1937. Am J Psychiatry 1994, 151(6Suppl):240-247.
37. Frier BM. Hypoglycemia. Encyclopedia of Stress (Second Edition) pp. 408-13.
38. Auer R.N. Progress review: hypoglycemic brain damage. Stroke 1986, 17:699-708.
39. Haces M.L., Montiel T., Massieu L. Selective vulnerability of brain régions to oxidative stress in a non-coma model of insulin-induced hypoglycemia. Neuroscience 2010, 165:28-38.
40. Shirayama H., Ohshiro Y., Kinjo Y., Taira S., Teruya I., Nakachi K., et al. Acute brain injury in hypoglycaemia-induced hemiplegia. Diabet Med 2004, 21:623-624.
41. Lee B.W., Jin E.S., Hwang H.S., Yoo H.J., Jeong J.H. A case of hypoglycemic brain injuries with cortical laminar necrosis. J Korean Med Sci 2010, 25:961-965.
42. Beck U., Rug R., Gerfelmeyer G. Intermittent unilateral cerebral symptoms in juvenile diabetes mellitus with hypoglycaemia. Nervenarzt 1982, 53:208-210.
43. Chinnapongse R.B., Odderson I.R., Johnson R.J. Hypoglycemic coma associated with brain infarcts. J Stroke Cerebrovasc Dis 1998, 7:154-156.
44. Liu Y.X., Lu B.X., Liu L., Chen X., Liu Y. Clinical analysis of 73 cases of hypoglycemia with brain dysfunctions. Di Yi Jun Yi Da Xue Xue Bao 2005, 25:1585-1588.
45. McAulay V., Deary I.J., Ferguson S.C., Frier B.M. Acute hypoglycemia in humans causes attentional dysfunction while nonverbal intelligence is preserved. Diabetes Care 2001, 24:1745-1750.
46. Jacobson A.M., Musen G., Ryan C.M., Silvers N., Cleary P., Waberski B., et al. Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 2007, 356:1842-1852.
47. Amiel S.A. Hypoglycaemia in diabetes mellitus-protecting the brain. Diabetologia 1997, 40(Suppl.2):S62-S68.
48. Whitmer R.A., Karter A.J., Yaffe K., Quesenberry C.P., Selby J.V. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 2009, 301:1565-1572.
49. Marks V. Hypoglycemia: insulin and conflicts with the law. Br J Diabetes Vasc Dis 2006, 6:281-285.
50. Stork A.D., van Haeften T.W., Veneman T.F. The decision not to drive during hypoglycemia in patients with type 1 and type 2 diabetes according to hypoglycemia awareness. Diabetes Care 2007, 30:2822-2826.
51. Cox D.J., Ford D., Gonder-Frederick L., Clarke W., Mazze R., Weinger K., et al. Driving mishaps among individuals with type 1 diabetes: a prospective study. Diabetes Care 2009, 32:2177-2180.
52. Cox D.J., Kovatchev B.P., Anderson S.M., Clarke W.L., Gonder-Frederick L.A. Type 1 Diabetic Drivers With and Without a History of Recurrent Hypoglycemia-Related Driving Mishaps: Physiological and performance differences during euglycemia and the induction of hypoglycemia. Diabetes Care 2010, 33:2430-2435.
53. Cox D.J., Gonder-Frederick L.A., Kovatchev B.P., Clarke W.L. Selftreatment of hypoglycemia while driving. Diabetes Res Clin Pract 2001, 54:17-26.
54. Tiengo A., Fadini G.P., Avogaro A. The metabolic syndrome, diabetes and lung dysfunction. Diabetes Metab 2008, 34:447-454.
55. George C.F. Sleep apnea, alertness, and motor vehicle crashes. Am J Respir Crit Care Med 2007, 176:954-956.